PDE5A and erectile dysfunction: Within this evolving landscape, phosphodiesterase type 5 (PDE5) inhibitors, originally developed for and extensively validated in the treatment of erectile dysfunction, have begun to receive attention for their potential roles beyond penile hemodynamics [3].